Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000262417

Medchemexpress LLC Diabzi sting agonist-1 | 2138498-18-5 | MFCD31746907 | 99.9% | 849.94 g/mol | C42H51N13O7 | 5 MG
SDP

Catalog No. 5000262417
Encompass_Preferred

diABZI STING agonist-1 (tautomerism) is a non-nucleotide small-molecule agonist of the STING (stimulator of interferon genes) signaling pathway. It activates STING with reported EC50 values of 130 nM (human) and 186 nM (mouse), is supplied for research use only, and is provided in a small-scale research vial.

  • Potent STING receptor agonist with low-nanomolar activity
  • Reported EC50 values: human 130 nM, mouse 186 nM
  • High chemical purity (99.9%)
  • Molecular weight 849.94 g/mol; formula C42H51N13O7
  • Supplied as a 5 mg research vial
  • Used in studies demonstrating STING-dependent activation in vivo and in vitro

Catalog No. 50-002-62417 Supplier Medchemexpress LLC Supplier No. HY1129215MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

diABZI STING agonist-1 (tautomerism) is a non-nucleotide small-molecule agonist of the STING (stimulator of interferon genes) signaling pathway. It activates STING with reported EC50 values of 130 nM (human) and 186 nM (mouse), is supplied for research use only, and is provided in a small-scale research vial.

  • Potent STING receptor agonist with low-nanomolar activity
  • Reported EC50 values: human 130 nM, mouse 186 nM
  • High chemical purity (99.9%)
  • Molecular weight 849.94 g/mol; formula C42H51N13O7
  • Supplied as a 5 mg research vial
  • Used in studies demonstrating STING-dependent activation in vivo and in vitro

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.